LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹176 Cr | ₹157 Cr | ₹152 Cr | ₹186 Cr | ₹174 Cr |
What is the latest Total Liabilities ratio of LYKA LABS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹152 Cr |
| Mar2022 | ₹186 Cr |
| Mar2021 | ₹174 Cr |
How is Total Liabilities of LYKA LABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹176 Cr | 12.34 | |
| Mar2024 | ₹157 Cr | 3.52 | |
| Mar2023 | ₹152 Cr | -18.37 | |
| Mar2022 | ₹186 Cr | 6.88 | |
| Mar2021 | ₹174 Cr | - | |
Compare Total Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹269.5 Cr | -2.3% | -5.5% | -52.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -2.3% |
-5.5% |
-52.7% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses